South Africa Neurology Devices Market: Market Size & Forecast 2026

South Africa's neurology devices market represents a significant segment of the country's broader medical device industry, which totals approximately $1.12 billion in 2025. The neurology segment is expected to register a compound annual growth rate of 4.5% through 2030, broadly in line with regional MEA trends where the wider neurology devices market reaches $433 million by 2030 at a 5.9% CAGR. The neurorehabilitation devices sub-segment is particularly dynamic, forecast to reach $26.5 million by 2030 with a robust 15.7% CAGR, reflecting growing emphasis on post-acute neurological care.

• •Market valued at $264.37 million in 2025 with 4.5% projected CAGR through 2030
• •Neurorehabilitation devices sub-segment growing at 15.7% CAGR to reach $26.5 million by 2030
• •Part of South Africa's overall $1.12 billion medical device market, which grows at 6.88% CAGR

The increasing prevalence of neurological disorders, including stroke, Parkinson's disease, epilepsy, and traumatic brain injuries, is a primary catalyst for market expansion across South Africa. An aging population, rising rates of lifestyle-related conditions such as hypertension and diabetes, and improved diagnostic capabilities are contributing to higher disease incidence and greater demand for neurology interventions. Government initiatives, including the DTIC MedTech Master Plan, aim to strengthen the local medical technology sector, while expanding healthcare coverage and investment in hospital infrastructure are improving patient access to advanced neurological care.

• •Rising burden of stroke, Parkinson's disease, epilepsy, and neurodegenerative disorders driving demand
• •Aging population and lifestyle-related conditions increasing neurological disease prevalence
• •DTIC MedTech Master Plan and healthcare infrastructure expansion supporting market access

The neurology devices market spans multiple product categories, with neurovascular devices representing a major regional segment valued at $870.8 million across MEA by 2033 at a 5.4% CAGR. Deep brain stimulation devices in the MEA region are valued at $37.1 million in 2025 and are estimated to grow at 4.2% CAGR through 2033. South Africa leads the MEA neurology devices landscape, though the region as a whole grows more slowly than South Africa's overall medical device market, which posts a 6.88% CAGR.

• •MEA neurovascular devices market projected at $870.8 million by 2033 (5.4% CAGR from 2025)
• •MEA deep brain stimulation devices valued at $37.1 million in 2025 (4.2% CAGR to 2033)
• •South Africa dominates the MEA neurology devices market, with faster growth than the regional average

What are the recent trends and outlook?

The market outlook through 2030 remains positive, with the 4.5% CAGR reflecting steady demand underpinned by demographic and epidemiological trends. Technological advancements in minimally invasive neurovascular procedures, AI-assisted neuroimaging, and portable diagnostic devices are expected to shape product development and procurement decisions. The broader South African healthcare sector's push toward universal health coverage and improved private-public healthcare integration may expand the addressable patient base for neurology devices, while growing medical tourism in selected specialties could create additional demand channels.

• •Steady 4.5% CAGR projected through 2030 supported by aging demographics and rising neurological disease burden
• •AI-assisted diagnostics, minimally invasive interventions, and portable neuroimaging driving product innovation
• •Universal health coverage initiatives and medical tourism trends may expand market access opportunities